Structure Therapeutics Inc. Common Stock, Capital Shares Reserved for Future Issuance
Structure Therapeutics Inc. (GPCR) had Common Stock, Capital Shares Reserved for Future Issuance of 38.25 million shares as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-02-26
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 38.25M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 26.69M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 21.09M shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 75.72M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 38.25M shares 10-K · filed 2026-02-26 |
| 2024-12-31 | 26.69M shares 10-K · filed 2026-02-26 |
| 2023-12-31 | 21.09M shares 10-K · filed 2025-02-27 |
| 2022-12-31 | 75.72M shares 10-K · filed 2024-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |